The role of the private sector in noncommunicable disease prevention and management in low- and middle-income countries: a series of systematic reviews and thematic syntheses

References

• Abdool-Gaffar, M. S., Ambaram, A., Ainslie, G. M., Bolliger, C. T., Feldman, C., Geffen, L., Irusen, E. M., Joubert, J., Lalloo, U. G., Mabaso, T. T., Nyamande, K. (2011). Guideline for the management of chronic obstructive pulmonary disease–2011 update. South African Medical Journal, 101(1 Pt 2), 63–21.
   PubMedGoogle Scholar
• AB InBev. (2018). Reducing the harmful use of alcohol and improving road safety: AB InBev’s progress report on its global smart drinking goals and contribution to United Nations sustainable development goals 3 and 17. https://abinbevfoundation.org/advisors-partners
   Google Scholar
• Abraham, G., Khanna, P., Mathew, M., Pushpkala, P., Mehrotra, A., Sairam, A., & Ali, A. A. (2009). How to make peritoneal dialysis affordable in developing countries. Contributions to Nephrology, 163, 243–249.
   Web of Science ®Google Scholar
• The Advisory Group on the Governance of the Private Sector for UHC. (2020). Engaging the private health service delivery sector through governance in mixed health systems :strategyreport of the WHO Advisory Group on the Governance of the Private Sector for Universal Health Coverage. Geneva: World HealthOrganization.
   Google Scholar
• Agarwal, S. K. (2005). Chronic kidney disease and its prevention in India. Kidney International, 68, S41–45. https://doi.org/10.1111/J.1523-1755.2005.09808.X
   Google Scholar
• Ahmed, S., Ware, P., Visca, R., Bareil, C., Chouinard, M. C., Desforges, J., Finlayson, R., Fortin, M., Gauthier, J., Grimard, D., & Guay, M. (2015). The prevention and management of chronic disease in primary care: Recommendations from a knowledge translation meeting. BMC Research Notes, 8, 571.
   PubMedGoogle Scholar
• Alizadeh, G., Gholipour‎, K., Khosravi, M. F., & Khodayari-Zarnaq, R. (2020). Preventive community-based strategies of cardiovascular diseases in Iran: A multi-method study. Social Work in Public Health, 35(4), 177–186.
   PubMed Web of Science ®Google Scholar
• Allen, L. N. (2017). Financing national non-communicable disease responses. Global Health Action, 10(1).
   Google Scholar
• Allotey, P., Davey, T., & Reidpath, D. D. (2014). NCDs in low and middle-income countries - assessing the capacity of health systems to respond to population needs. BMC Public Health, 14(2), 1–3.
   PubMedGoogle Scholar
• Angwenyi, V., Aantjes, C., Bunders-Aelen, J., Criel, B., & Lazarus, J. V. (2020). Context matters: A qualitative study of the practicalities and dilemmas of delivering integrated chronic care within primary and secondary care settings in a rural malawian district. BMC Family Practice, 21(1), 1–12.
   Web of Science ®Google Scholar
• Anson, A., Ramay, B., de Esparza, A. R., & Bero, L. (2012). Availability, prices and affordability of the world health organization’s essential medicines for children in guatemala. Globalization and Health, 8, 22.
   PubMed Web of Science ®Google Scholar
• Armstrong-Hough, M., Sharma, S., Kishore, S. P., Akiteng, A. R., & Schwartz, J. I. (2020). Variation in the availability and cost of essential medicines for non-communicable diseases in Uganda: A descriptive time series analysis. Plos One, 15, (12), e0241555.
   PubMed Web of Science ®Google Scholar
• Ashigbie, P. G., Rockers, P. C., Laing, R. O., Cabral, H. J., Onyango, M. A., Buleti, J. P. L., & Wirtz, V. J. (2020). Availability and prices of medicines for non-communicable diseases at health facilities and retail drug outlets in Kenya: A cross-sectional survey in eight counties. BMJ Open, 10(5), e035132.
   Web of Science ®Google Scholar
• AstraZeneca. (2021). Healthy heart Africa. https://www.astrazeneca.com/sustainability/access-to-healthcare/healthy-heart-africa.html
   Google Scholar
• Atre, S. (2015). Addressing policy needs for prevention and control of type 2 diabetes in India. Perspectives in Public Health, 135(5), 257–263.
   Web of Science ®Google Scholar
• AVON Global Scholars. (n.d.). Boston University. https://sites.bu.edu/coeinwomenshealth/education/avon-global-scholars/
   Google Scholar
• Balasubramaniam, R., Benaragama, B. V. S. H., & Sri Ranganathan, S. (2014). A national survey of price and affordability of key essential medicines for children in Sri Lanka. Indian Journal of Pediatrics, 81(4), 362–367.
   Web of Science ®Google Scholar
• Ben Romdhane, H., Tlili, F., Skhiri, A., Zaman, S., & Phillimore, P. (2015). Health system challenges of NCDs in Tunisia. International Journal of Public Health, 60(Suppl1), S39–46.
   Google Scholar
• Beran, D., Mirza, Z., & Dong, J. (2019). Access to insulin: Applying the concept of security of supply to medicines. Bulletin of the World Health Organization, 97(5) , 358–364.
   Web of Science ®Google Scholar
• Berendes, S., Heywood, P., Oliver, S., Jenkins, R., & Garner, P. (2011). Quality of private and public ambulatory health care in low and middle income countries: Systematic review of comparative studies. PLoS Medicine, 8(4), e1000433.
   PubMed Web of Science ®Google Scholar
• Bergman, M., Buysschaert, M., Schwarz, P. E. H., Albright, A., Narayan, K. M. V., & Yach, D. (2012). Diabetes prevention: Global health policy and perspectives from the ground. Diabetes Manag, 2(4), 309–321.
   Google Scholar
• Bhattacharyya, O., Khor, S., McGahan, A., Dunne, D., Daar, A. S., & Singer, P. A. (2010). Innovative health service delivery models in low and middle income countries - what can we learn from the private sector? Health policy and systems research, 8, 24.
   PubMed Web of Science ®Google Scholar
• Bhojani, U., Devedasan, N., Mishra, A., De Henauw, S., Kolsteren, P., & Criel, B. (2014). Health system challenges in organizing quality diabetes care for urban poor in South India. Plos One, 9(9), e106522.
   Web of Science ®Google Scholar
• Bhojani, U., Thriveni, B. S., Devadasan, R., Munegowda, C. M., Devadasan, N., Criel, B., & Kolsteren, P. (2012). Challenges in organizing quality diabetes care for the urban poor: A local health system perspective. BMC Proceedings, 65(6), 1–3.
   Google Scholar
• Bhuvan, K. C., Heydon, S., & Norris, P. (2019). Access to and use of medicines in the annapurna region of Western Nepal and possible impacting factors. Journal of Pharmaceutical Policy and Practice, 12, 11.
   Google Scholar
• Bigdeli, M., Jacobs, B., Men, C. R., Nilsen, K., Van Damme, W., & Dujardin, B. (2016). Access to treatment for diabetes and hypertension in rural cambodia: Performance of existing social health protection schemes. Plos One, 11(1), e0146147.
   Web of Science ®Google Scholar
• Bintabara, D., Mpondo, B. C. T., & Musinguzi, G. (2018). Preparedness of lower-level health facilities and the associated factors for the outpatient primary care of hypertension: Evidence from tanzanian national survey. Plos One, 13(2), e0192942.
   Web of Science ®Google Scholar
• Bissell, K., Perrin, C., & Beran, D. (2016). Access to essential medicines to treat chronic respiratory disease in low-income countries. The International Journal of Tuberculosis and Lung Disease, 20(6), 717–728.
   Web of Science ®Google Scholar
• Bloom, D. E., Cafiero, E., Jané-Llopis, E., Abrahams-Gessel, S., Bloom, L. R., Fathima, S., Feigl, A. B., Gaziano, T., Hamandi, A., Mowafi, M., O’Farrell, D. (2011). The Global Economic Burden of Non-communicable Diseases | World Economic Forum. https://www.weforum.org/reports/global-economic-burden-non-communicable-diseases
   Google Scholar
• Bloomfield, G. S., Xavier, D., Belis, D., Alam, D., Davis, P., Prabhakaran, D., Ghannem, H., Gilman, R. H., Kamath, D., Kimaiyo, S., & Levitt, N. (2016). Training and capacity building in LMIC for research in heart and lung diseases: The NHLBI-UnitedHealth global health centers of excellence program. Global Heart, 11(1), 17–25.
   PubMed Web of Science ®Google Scholar
• Buse, K., Tanaka, S., & Hawkes, C. (2017). Healthy people and healthy profits? Elaborating a conceptual framework for governing the commercial determinants of non-communicable diseases and identifying options for reducing risk exposure. Globalization and Health, 13, 34.
   PubMed Web of Science ®Google Scholar
• Cameron, A., Ewen, M., Ross Degnan, D., Ball, D., & Laing, R. (2009). Medicine prices, availability, and affordability in 36 developing and middle-income countries: A secondary analysis. The Lancet, 373(9659), 240–249.
   PubMed Web of Science ®Google Scholar
• Carriedo, A., Koon, A. D., Encarnacion, L. M., Lee, K., Smith, R., & Walls, H. (2021). The political economy of sugar-sweetened beverage taxation in Latin America: Lessons from Mexico, Chile and Colombia. Globalization and Health, 17(1), 5.
   PubMed Web of Science ®Google Scholar
• Casswell, S. (2013). Vested interests in addiction research and policy why do we not see the corporate interests of the alcohol industry as clearly as we see those of the tobacco industry? Addiction, 108(4), 680–685.
   PubMed Web of Science ®Google Scholar
• Casswell, S. (2019). Addressing NCDs: Penetration of the producers of hazardous products into global health environment requires a strong response comment on ‘addressing NCDs: Challenges from industry market promotion and interferences’. International Journal of Health Policy and Management, 8(10), 607–609.
   Web of Science ®Google Scholar
• Cataife, G. (2012). Public versus private treatment of chronic diseases in seniors: Argentina, Brazil, Chile and Uruguay. Global Public Health, 7(10), 1157–1169.
   PubMed Web of Science ®Google Scholar
• Cattaneo, O., & Piemonte, C. (2021). Transition finance compendium: Challenges and recommendations for the development assistance committee. OECD Development Co-operation Working Papers, https://www.oecd.org/dac/transition-finance-compendium-90f219b1-en.htm
   Google Scholar
• Cetthakrikul, N., Phulkerd, S., Jaichuen, N., Sacks, G., & Tangcharoensathien, V. (2019). Assessment of the stated policies of prominent food companies related to obesity and non-communicable disease (NCD) prevention in Thailand. Globalization and Health, 15(1), 12.
   Google Scholar
• Checkley, W., Ghannem, H., Irazola, V., Kimaiyo, S., Levitt, N. S., Miranda, J. J., Niessen, L., Prabhakaran, D., Rabadán-Diehl, C., Ramirez-Zea, M., & Rubinstein, A. (2014). Management of NCD in low- and middle-income countries. Global Heart, 9(4), 431–443.
   PubMedGoogle Scholar
• Clarke, D., Doerr, S., Hunter, M., Schmets, G., Soucat, A., & Paviza, A. (2019). The private sector and universal health coverage. Bulletin of the World Health Organization, 97(6), 434–435.
   PubMed Web of Science ®Google Scholar
• Clarke, D., & Paviza, A. (2018). The private sector, universal health coverage and primary health care. https://www.who.int/publications/i/item/WHO-HIS-SDS-2018.53
   Google Scholar
• Coriakula, J., Moodie, M., Waqa, G., Latu, C., Snowdon, W., & Bell, C. (2018). The development and implementation of a new import duty on palm oil to reduce non-communicable disease in fiji. Globalization and Health, 14(1), 91.
   Google Scholar
• Dabare, P. R. L., Wanigatunge, C. A., & Beneragama, B. H. (2014). A national survey on availability, price and affordability of selected essential medicines for non communicable diseases in Sri Lanka. BMC Public Health, 14, 817. https://doi.org/10.1186/1471-2458-14-817
   Web of Science ®Google Scholar
• da Cruz Paula, A., de Varge Maldonado, J. M. S., & Grabois Gadelha, C. A. (2020). Healthcare telemonitoring and business dynamics: Challenges and opportunities for SUS. Revista de Saude Publica, 54, 65.
   Web of Science ®Google Scholar
• Das, M., Choudhury, S., Maity, S., Hazra, A., Pradhan, T., Pal, A., & Roy, R. (2017). Generic versus branded medicines: An observational study among patients with chronic diseases attending a public hospital outpatient department. Journal of Natural Science, Biology, and Medicine, 8(1), 26–31.
   Google Scholar
• Dearing, J. W., & Cox, J. G. (2018). Diffusion of innovations theory, principles, and practice. Health Affairs, 37(2), 183–190.
   PubMed Web of Science ®Google Scholar
• Dobe, M. (2012). Health promotion for prevention and control of non-communicable diseases: Unfinished agenda. Indian Journal of Public Health, 56(3), 180–186. https://doi.org/10.4103/0019-557X.104199
   PubMedGoogle Scholar
• Doshi, P. P., Bhosai, S. J., Goldmann, D., & Udayakumar, K. (2021). Imagining the future of primary care: A global look at innovative health care delivery. NEJM Catal. https://doi.org/10.1056/CAT.20.0481
   Google Scholar
• Dugee, O., Palam, E., Dorjsuren, B., & Mahal, A. (2018). Who is bearing the financial burden of non-communicable diseases in Mongolia? Journal of Global Health, 8(1), 010415.
   Web of Science ®Google Scholar
• Dutta, A., & Ly, C. (2018). Financing the health systems of the future: A proposed framework for including non-communicable diseases. World Bank. https://blogs.worldbank.org/health/financing-health-systems-future-proposed-framework-including-non-communicable-diseases
   Google Scholar
• Ebrahim, S., Pearce, N., Smeeth, L., JP, C., Jaffar, S., & Piot, P. (2013). Tackling non-communicable diseases in low- and middle-income countries: Is the evidence from high-income countries all we need? PLoS Medicine, 10(1), e1001377.
   PubMed Web of Science ®Google Scholar
• Elias, M. A., Pati, M. K., Aivalli, P., Srinath, B., Munegowda, C., Shroff, Z. C., Bigdeli, M., & Srinivas, P. N. (2018). Preparedness for delivering non-communicable disease services in primary care: Access to medicines for diabetes and hypertension in a district in south India. BMJ Global Health, 2(Suppl 3), e000519.
   Google Scholar
• El-Saharty, S., Ahsan, K. Z., Koehlmoos, T. L. P., & Engelgau, M. M. (2013). Tackling noncommunicable diseases in Bangladesh: Now is the time. World Bank. https://doi.org/10.1596/978-0-8213-9920-0
   Google Scholar
• El-Sayed, A. M., Palma, A., Freedman, L. P., & Kruk, M. E. (2015). Does health insurance mitigate inequities in non-communicable disease treatment? Evidence from 48 low- and middle-income countries. Health Policy, 119(9), 1164–1175.
   Web of Science ®Google Scholar
• Engelgau, M. M., Sampson, U. K., Rabadan Diehl, C., Smith, R., Miranda, J., Bloomfield, G. S., Belis, D., Narayan, K. M. V., Rubinstein, A., He, J., Alam, D. S., Peters, D. H., Wu, Y., Yan, L. L., Merson, M., Ramirez, M., Caballero, B., Xavier, D., Yusuf, S. … Aluko, E. (2016). Tackling NCD in LMIC: Achievements and lessons learned from the NHLBI-UnitedHealth global health centers of excellence program. Global Heart, 11(1), 5–15.
   Web of Science ®Google Scholar
• Evert, A., Fleming, A., Gaudiani, L. M., Guggenmos, K. J., Kaufer, D. I., McGill, J. B., Verderese, C. A., & Martinez, J. (2019). Culinary medicine: Advancing a framework for healthier eating to improve chronic disease management and prevention. Clinical Therapeutics, 41(10), 2184–2198.
   Web of Science ®Google Scholar
• FAO, I. F. A. D., UNICEF, W. F. P., & WHO. (2020). The state of food security and nutrition in the World 2020. Transforming food systems for affordable healthy diets. https://www.unicef.org/reports/state-of-food-security-and-nutrition-2020
   Google Scholar
• Ganju, A., Goulart, A. C., Ray, A., Majumdar, A., Jeffers, B. W., Llamosa, G., Cañizares, H., Ramos-Cañizares, I. J., Fadhil, I., Subramaniam, K., Lim, L. L., El Bizri, L., Ramesh, M., Guilford, M., Ali, R., Devi, R. D., Malik, R. A., Potkar, S., & Wang, Y. P. (2020). Systemic solutions for addressing non-communicable diseases in low- and middle-income countries. Journal of Multidisciplinary Healthcare, 13, 693–707.
   Web of Science ®Google Scholar
• George, A. A. (2018). An unwelcome seat at the table: The role of big food in public and private standard-setting and its implications for NCD regulation. QUT Law Review, 18(1), 156–168.
   Web of Science ®Google Scholar
• Global Systems for Mobile Communications. (2019). CASALUD: A suite of digital health services for the prevention and management of NCDs. https://www.gsma.com/mobilefordevelopment/resources/carlos-slim-foundation-case-study/
   Google Scholar
• Gómez, E. J. (2019). Coca-cola’s political and policy influence in Mexico: Understanding the role of institutions, interests and divided society. Health Policy and Planning, 34(7), 520–528.
   PubMed Web of Science ®Google Scholar
• Goroff, M., & Reich, M. R. (2010). Partnerships to provide care and medicine for chronic diseases: A model for emerging markets. Health Affairs, 29(12), 2206–2213.
   Web of Science ®Google Scholar
• Gortmaker, S. L., Swinburn, B. A., Levy, D., Carter, R., Mabry, P. L., Finegood, D. T., Huang, T., Marsh, T., & Moodie, M. L. (2012). Changing the future of obesity: Science, policy, and action. Obstetrical & Gynecological Survey, 67(1), 6–8.
   Web of Science ®Google Scholar
• Grancelli, H. (2005). Randomised trial of telephone intervention in chronic heart failure: DIAL trial. BMJ British Medical Journal, 331(7514), 425.
   Web of Science ®Google Scholar
• Hancock, C., Kingo, L., & Raynaud, O. (2011). The private sector, international development and NCDs. Globalization and Health, 7(1), 23.
   Google Scholar
• Hawker, S., Payne, S., Kerr, C., Hardey, M., & Powell, J. (2002). Appraising the evidence: Reviewing disparate data systematically. Qualitative Health Research, 12(9), 1284–1299.
   PubMed Web of Science ®Google Scholar
• Hawkes, C., & Buse, K. (2011). Public health sector and food industry interaction: It’s time to clarify the term ‘partnership’ and be honest about underlying interests. European Journal of Public Health, 21(4), 400–401.
   PubMed Web of Science ®Google Scholar
• Healthy Caribbean Coalition & NCD Alliance. (2017). Preventing Childhood Obesity in the Caribbean. https://ncdalliance.org/resources/preventing-childhood-obesity-in-the-caribbean
   Google Scholar
• Heidari, E., Varmaghani, M., & Abdollahiasl, A. (2019). Availability, pricing and affordability of selected medicines for noncommunicable diseases. Eastern Mediterranean Health Journal, 25(7), 473–480.
   Web of Science ®Google Scholar
• Herzlinger, R. E. (2006, May). Why innovation in health care is so hard. Harvard Business Review. https://hbr.org/2006/05/why-innovation-in-health-care-is-so-hard
   PubMed Web of Science ®Google Scholar
• Holt, T., Millroy, L., & Mmopi, M. (2017). Winning in Nigeria: Pharma’s next frontier. Pharmaceuticals & Medical Products. https://www.mckinsey.com/industries/pharmaceuticals-and-medical-products/our-insights/winning-in-nigeria-pharmas-next-frontier
   Google Scholar
• Hospedales, C. J., & Jané-Llopis, E. (2011). A multistakeholder platform to promote health and prevent noncommunicable diseases in the region of the americas: The pan american health organization partners forum for action. Journal of Health Communication, 16(Sup 2), 191–200.
   Google Scholar
• IFC. (2011). Public-private partnership stories. India: Andhra Pradesh radiology. World Bank Group. https://policycommons.net/artifacts/1516322/india-andhra-pradesh-radiology/2192732/
   Google Scholar
• Institute for Health Metrics and Evaluation (IHME). (2020). Non-communicable diseases — level 1 cause. University of Washington. http://www.healthdata.org/results/gbd_summaries/2019/non-communicable-diseases-level-1-cause
   Google Scholar
• Jaichuen, N., Phulkerd, S., Certthkrikul, N., Sacks, G., & Tangcharoensathien, V. (2018). Corporate political activity of major food companies in Thailand: An assessment and policy recommendations. Globalization and Health, 14(1), 1–11.
   Google Scholar
• Johnson, M., Wilkinson, J., Gardner, A., Kupfer, L. E., Kimaiyo, S., & Von Zinkernagel, D. (2018). Global partnerships to support noncommunicable disease care in low and middle-income countries: Lessons from HIV/AIDS. AIDS, 32(Suppl 1), S75–82.
   Google Scholar
• Jones, J. Q. (2021). Global action on financing cervical cancer elimination: Funding secondary prevention services in low resource settings. https://eiuperspectives.economist.com/healthcare/global-action-financing-cervical-cancer-elimination-funding-secondary-prevention-services-low
   Google Scholar
• Joshi, R., Alim, M., Kengne, A. P., Jan, S., Maulik, P. K., Peiris, D., & Patel, A. A. (2014). Task shifting for non-communicable disease management in low and middle income countries – a systematic review. Plos One, 9(8), e103754.
   PubMed Web of Science ®Google Scholar
• Kanzler, L., & Ng, A. (2012). The future of public and private health care insurance in Asia. In D. Coady, B. J. Clements, & S. Gupta (Eds.), The economics of public health care reform in advanced and emerging economies (pp. 55–68). International Monetary Fund. https://doi.org/10.5089/9781616352448.071
   Google Scholar
• Kasonde, L., Tordrup, D., Naheed, A., Zeng, W., Ahmed, S., & Babar, Z. U. (2019). Evaluating medicine prices, availability and affordability in Bangladesh using world health organisation and health action international methodology. BMC Health Services Research, 19, 383.
   PubMed Web of Science ®Google Scholar
• Khayatzadeh-Mahani, A., Ruckert, A., & Labonté, R. (2018). Could the WHO’s framework on engagement with non-state actors (FENSA) be a threat to tackling childhood obesity? Global Public Health, 13(9), 1337–1340.
   PubMed Web of Science ®Google Scholar
• Khuluza, F., & Haefele-Abah, C. (2019). The availability, prices and affordability of essential medicines in Malawi: A cross-sectional study. Plos One, 14(2), e0212125.
   PubMed Web of Science ®Google Scholar
• Kickbusch, I., Allen, L., & Franz, C. (2016). The commercial determinants of health. Lancet Glob Heal, 4(12), e895–896.
   PubMed Web of Science ®Google Scholar
• Kishore, S. P., Kolappa, K., Jarvis, J. D., Park, P. H., Belt, R., Balasubramaniam, T., & Kiddell-Monroe, R. (2015). Overcoming obstacles to enable access to medicines for noncommunicable diseases in poor countries. Health Affairs, 34(9), 1569–1577.
   Web of Science ®Google Scholar
• Kraak, V. I., Harrigan, P. B., Lawrence, M., Harrison, P. J., Jackson, M. A., & Swinburn, B. (2012). Balancing the benefits and risks of public-private partnerships to address the global double burden of malnutrition. Public Health Nutrition, 15(3), 503–517.
   Web of Science ®Google Scholar
• Laar, A. K., Adler, A. J., Kotoh, A. M., Legido-Quigley, H., Lange, I. L., Perel, P., & Lamptey, P. (2019). Health system challenges to hypertension and related non-communicable diseases prevention and treatment: Perspectives from Ghanaian stakeholders. BMC Health Services Research, 19, 693.
   Web of Science ®Google Scholar
• Ladusingh, L., Mohanty, S. K., & Thangjam, M. (2018). Triple burden of disease and out of pocket healthcare expenditure of women in India. Plos One, 13(5), e0196835.
   PubMed Web of Science ®Google Scholar
• Lambert, E. V., & Kolbe-Alexander, T. L. (2013). Innovative strategies targeting obesity and non-communicable diseases in South Africa: What can we learn from the private healthcare sector? Obesity Reviews : An Official Journal of the International Association for the Study of Obesity, 14(2), 141–149.
   Google Scholar
• Lauber, K., Ralston, R., Mialon, M., Carriedo, A., & Gilmore, A. B. (2020). Non-communicable disease governance in the era of the sustainable development goals: A qualitative analysis of food industry framing in WHO consultations. Globalization and Health, 16(1), 76.
   Web of Science ®Google Scholar
• Lekshmi, S., Mohanta, G. P., Revikumar, K. G., & Manna, P. K. (2014). Study on availability and affordability of anti hypertensive medicines in the State of Kerala. International Journal of Pharmacy and Pharmaceutical Sciences, 6(10), 364–369.
   Google Scholar
• Lewis, M., Penteado, E., & Malik, A. M. (2015). Brazil’s mixed public and private hospital system. World Hospitals and Health Services Journal, 22–26. https://pubmed.ncbi.nlm.nih.gov/26521382/
   Google Scholar
• Malekzadeh, A., Michels, K., Wolfman, C., Anand, N., & Sturke, R. (2020). Strengthening research capacity in LMICs to address the global NCD burden. Global Health Action, 13(1), 1846904.
   Web of Science ®Google Scholar
• Mariath, A. B., & Martins, A. P. B. (2020). Ultra-processed products industry operating as an interest group. Revista de Saude Publica, 54, 107.
   PubMed Web of Science ®Google Scholar
• Medtronic Foundation. (n.d.). Addressing noncommunicable diseases by building capacity, community, and commitment.
   Google Scholar
• Mendis, S., & Chestnov, O. (2013). Policy reform to realize the commitments of the political declaration on noncommunicable diseases. British Medical Bulletin, 105, 7–27.
   Web of Science ®Google Scholar
• Mendis, S., Fukino, K., Cameron, A., Laing, R., Filipe, J. A., Khatib, O., Leowski, J., & Ewen, M. (2007). The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries. Bulletin of the World Health Organization, 85(4), 279–288.
   PubMed Web of Science ®Google Scholar
• Merck, K. (2021). Merck foundation capacity advancement & nationwide diabetes blue point program. Merck Foundation. https://merck-foundation.com/our-programs/Merck-Foundation-Capacity-Advancement-and-Nationwide-Diabetes-Blue-Point-Program
   Google Scholar
• Mhlanga, B. S., & Suleman, F. (2014). Price, availability and affordability of medicines. African Journal of Primary Health Care and Family Medicine, 6(1), 604.
   Google Scholar
• Mialon, M., Charry, D. A. G., Cediel, G., Crosbie, E., Scagliusi, F. B., & Pérez Tamayo, E. M. (2020). ‘The architecture of the state was transformed in favour of the interests of companies’: Corporate political activity of the food industry in Colombia. Globalization and Health, 16(1), 97.
   Web of Science ®Google Scholar
• Mialon, M., & Da Silva Gomes, F. (2019). Public health and the ultra-processed food and drink products industry: Corporate political activity of major transnationals in Latin America and the Caribbean. Public Health Nutrition, 22(10), 1898–1908.
   PubMed Web of Science ®Google Scholar
• Mialon, M., Gaitan Charry, D. A., Cediel, G., Crosbie, E., Scagliusi, F. B., & Perez Tamayo, E. M. (2021). ‘I had never seen so many lobbyists’: Food industry political practices during the development of a new nutrition front-of-pack labelling system in Colombia. Public Health Nutrition, 24(9), 2737–2745.
   Web of Science ®Google Scholar
• Mialon, M., Swinburn, B., Wate, J., Tukana, I., & Sacks, G. (2016). Analysis of the corporate political activity of major food industry actors in Fiji. Globalization and Health, 12(1), 1–14.
   Google Scholar
• Moodie, R., Stuckler, D., Monteiro, C., Sheron, N., Neal, B., Thamarangsi, T., Lincoln, P., & Casswell, S. (2013). Profits and pandemics: Prevention of harmful effects of tobacco, alcohol, and ultra-processed food and drink industries. The Lancet, 381(9867), 670–679.
   PubMed Web of Science ®Google Scholar
• Moscetti, C. W., & Taylor, A. L. (2015). Take me to your liter: Politics, power, and public-private partnerships with the sugar-sweetened beverage industry in the post-2015 development agenda. Washington International Law Journal, 24(3), 635–671.
   Google Scholar
• Mukherjee, S., Haddad, S., & Narayana, D. (2011). Social class related inequalities in household health expenditure and economic burden: Evidence from Kerala, south India. International Journal for Equity in Health, 10(1), 1.
   PubMedGoogle Scholar
• Musinguzi, G., Bastiaens, H., Wanyenze, R. K., Mukose, A., Van Geertruyden, J. P., & Nuwaha, F. (2015). Capacity of health facilities to manage hypertension in Mukono and Buikwe Districts in Uganda: Challenges and recommendations. Plos One, 10(11), e0142312.
   PubMed Web of Science ®Google Scholar
• Myers, A., Fig, D., Tugendhaft, A., Mandle, J., Myers, J., & Hofman, K. (2017). Sugar and health in South Africa: Potential challenges to leveraging policy change. Global Public Health, 12(1), 98–115.
   PubMed Web of Science ®Google Scholar
• Nari Kahle, H., Dubiel, A., Ernst, H., & Prabhu, J. (2013). The democratizing effect of frugal innovation: Implications for inclusive growth and state-building. Journal of Indian Business Research, 5(4), 220–234.
   Google Scholar
• Novo Nordisk. (2017). Base of the pyramid programme. Novo Nordisk.
   Google Scholar
• Oladepo, O., Oluwasanu, M., & Abiona, O. (2018). Analysis of tobacco control policies in Nigeria: Historical development and application of multi-sectoral action. BMC Public Health, 18(S1), 959.
   Google Scholar
• Oluwole, D., & Kraemer, J. (2013). Innovative public–private partnership: A diagonal approach to combating women’s cancers in Africa. Bulletin of the World Health Organization, 91(9), 691–696.
   PubMed Web of Science ®Google Scholar
• Omachonu, V. K., & Einspruch, N. G. (2010). Innovation in healthcare delivery systems: A conceptual framework. Innovation Journal: The Public Sector Innovation Journal, 15(1), 2.
   Google Scholar
• Ota, M. O. C., Kirigia, D. G., Asamoah-Odei, E., Drameh-Avognon, P. S., Olu, O., Malecela, M. N., Cabore, J. W., & Moeti, M. R. (2018). Proceedings of the first African health forum: Effective partnerships and intersectoral collaborations are critical for attainment of universal health coverage in Africa. BMC Proceedings, 12(S7), 8.
   Google Scholar
• Pandian, J. D., Srikanth, V., Read, S. J., & Thrift, A. G. (2007). Poverty and stroke in India: A time to act. Stroke, 38(11), 3063–3069.
   PubMed Web of Science ®Google Scholar
• Parikh, H. S. (2013). Innovations in Chronic Disease Management (CDM) from Low and Middle Income Countries (LMICs). ProQuest.
   Google Scholar
• Pastakia, S. D., Tran, D. N., Manji, I., Schellhase, E., Karwa, R., Miller, M. L., Aruasa, W., & Khan, Z. M. (2020). Framework and case study for establishing impactful global health programs through academia - biopharmaceutical industry partnerships. Research in Social & Administrative Pharmacy : RSAP, 16(11), 1519–1525.
   Web of Science ®Google Scholar
• Patel, D. N., Lambert, E. V., da Silva, R., Greyling, M., Nossel, C., Noach, A., Derman, W., & Gaziano, T. (2010). The association between medical costs and participation in the vitality health promotion program among 948,974 members of a South African health insurance company. American journal of health promotion, 24(3), 199–204.
   PubMed Web of Science ®Google Scholar
• Pati, M. K., Swaroop, N., Kar, A., Aggarwal, P., Jayanna, K., & Van Damme, W. (2020). A narrative review of gaps in the provision of integrated care for noncommunicable diseases in India. Public Health Reviews, 41, 8.
   Web of Science ®Google Scholar
• Pfizer, U. (2020). Leading the conversation on noncommunicable diseases worldwide: An evidence-based review of key research and strategies to develop sustainable solutions. Pfizer Upjohn. https://www.pfizer.com/upjohn_ncd_white_paper
   Google Scholar
• Plum, A., Tanniru, M., & Khuntia, J. (2020). An innovation platform for diffusing public health practices across a global network. Health Policy and Technology, 9(2), 225–234.
   Web of Science ®Google Scholar
• Polanczyk, C. A., & Ribeiro, J. P. (2009). Coronary artery disease in Brazil: Contemporary management and future perspectives. Heart, 95(11), 870–876.
   Web of Science ®Google Scholar
• Prescott, D., & Stibbe, D. (2017). Better together: Unleashing the Power of the Private Sector to Tackle Non-Communicable Diseases. The Partnering Initiative (Oxford), UICC (Geneva) and Bupa (London).
   Google Scholar
• Rahman, M. M., Gilmour, S., Saito, E., Sultana, P., & Shibuya, K. (2013). Health-related financial catastrophe, inequality and chronic illness in Bangladesh. Plos One, 8(2), e56873.
   PubMed Web of Science ®Google Scholar
• Ratzan, S. C., Weinberger, M. B., Apfel, F., & Kocharian, G. (2013). The digital health scorecard: A new health literacy metric for NCD prevention and care. Global Heart, 8(2), 171–179.
   Google Scholar
• Rawal, L. B., Kharel, C., Yadav, U. N., Kanda, K., Biswas, T., Vandelanotte, C., Baral, S., & Abdullah, A. S. (2020). Community health workers for non-communicable disease prevention and control in Nepal: A qualitative study. BMJ Open, 10(12), e040350.
   Web of Science ®Google Scholar
• Reeves, M. (2011). The private sector’s role in combating NCDs. CSIS. https://www.csis.org/blogs/smart-global-health/private-sectors-role-combating-ncds
   Google Scholar
• Rockers, P. C., Laing, R. O., Ashigbie, P. G., Onyango, M. A., Mukiira, C. K., & Wirtz, V. J. (2019). Effect of novartis access on availability and price of non-communicable disease medicines in Kenya: A cluster-randomised controlled trial. Lancet Glob Heal, 7(4), e492–502.
   PubMed Web of Science ®Google Scholar
• Rouleau, G., Gagnon, M. P., Côté, J., Payne-Gagnon, J., Hudson, E., & Dubois, C. A. (2017). Impact of information and communication technologies on nursing care: Results of an overview of systematic reviews. Journal of Medical Internet Research, 19(4), e122.
   Google Scholar
• Sacks, G., Mialon, M., Vandevijvere, S., Trevena, H., Snowdon, W., Crino, M., & Swinburn, B. (2015). Comparison of food industry policies and commitments on marketing to children and product (re)formulation in Australia, New Zealand and Fiji. Critical Public Health, 25(3), 299–319.
   Web of Science ®Google Scholar
• Sado, E., & Sufa, A. (2016). Availability and affordability of essential medicines for children in the Western part of Ethiopia: Implication for access. BMC Pediatrics, 16, 40.
   PubMed Web of Science ®Google Scholar
• Saldarriaga, E. M., Vodicka, E., La Rosa, S., Valderrama, M., & Garcia, P. J. (2017). Point-of-care testing for anemia, diabetes, and hypertension: A pharmacy-based model in Lima, Peru. Annals of global health, 83(2), 394–404.
   Web of Science ®Google Scholar
• Sanni, S., Hongoro, C., Ndinda, C., & Wisdom, J. P. (2018). Assessment of the multi-sectoral approach to tobacco control policies in South Africa and Togo. BMC Public Health, 18(S1), 962.
   Google Scholar
• Schmutz, A., Salignat, C., Plotkina, D., Devouassoux, A., Lee, T., Arnold, M., Ervik, M., & Kelm, O. (2019). Mapping the global cancer research funding landscape. JNCI Cancer Spectrum, 3(4), pkz069.
   Google Scholar
• Shannon, G. D., Haghparast-Bidgoli, H., Chelagat, W., Kibachio, J., & Skordis-Worrall, J. (2019). Innovating to increase access to diabetes care in Kenya: An evaluation of novo nordisk’s base of the pyramid project. Global Health Action, 12(1), 105704.
   Web of Science ®Google Scholar
• Shellaby, L. S. & Henshall, S. (2018). Confronting the Investment Gap in Non-Communicable Disease Treatment and Care. https://www.uicc.org/resources/confronting-investment-gap-non-communicable-disease-treatment-and-care
   Google Scholar
• Shuvo, T. A., Islam, R., Hossain, S., Evans, J., Khatun, F., Ahmed, T., Gazi, R., & Adams, A. M. (2015). eHealth innovations in LMICs of Africa and Asia: A literature review exploring factors affecting implementation, scale-up, and sustainability. Innovation and Entrepreneurship in Health, 2, 95–106.
   Google Scholar
• Silva, V. L. C. E., Turci, S. R. B., de Oliveira, A. P. N., & Richter, A. P. (2017). Can the risk in public-private partnerships be classified? Cadernos de Saude Publica, 33(3), e00086316.
   Google Scholar
• Singh, T., Roy, P., Jamir, L., Gupta, S., Kaur, N., Jain, D. K., & Kumar, R. (2016). Assessment of universal healthcare coverage in a district of North India: A rapid cross-sectional survey using tablet computers. Plos One, 11(6), e0157831.
   Web of Science ®Google Scholar
• Smith, R., & Rabadan Diehl, C. (2016). Public-private partnership in countering NCD. Global Heart, 11(1), 143–144.
   Web of Science ®Google Scholar
• Subramanian, S., Gakunga, R., Kibachio, J., Gathecha, G., Edwards, P., Ogola, E., Yonga, G., Busakhala, N., Munyoro, E., Chakaya, J., Ngugi, N., Mwangi, N., Von Rege, D., Wangari, L. M., Wata, D., Makori, R., Mwangi, J., & Mwanda, W. (2018). Cost and affordability of non-communicable disease screening, diagnosis and treatment in Kenya: Patient payments in the private and public sectors. Plos One, 13(1), e0190113.
   Web of Science ®Google Scholar
• Suzuki, M., Webb, D., & Small, R. (2021). Competing frames in global health governance: An analysis of stakeholder influence on the political declaration on non-communicable diseases. International Journal of Health Policy and Management. https://doi.org/10.34172/ijhpm.2020.257
   Web of Science ®Google Scholar
• Syed, N., Rockers, P. C., Vian, T., Onyango, M., Laing, R. O., & Wirtz, V. J. (2018). Access to antihypertensive medicines at the household level: A study from 8 counties of Kenya. Global Heart, 13(4), 247–253.e5.
   Web of Science ®Google Scholar
• Tangcharoensathien, V., Chandrasiri, O., Kunpeuk, W., Markchang, K., & Pangkariya, N. (2019). Addressing NCDs: Challenges from industry market promotion and interferences. International Journal of Health Policy and Management, 8(5), 256–260.
   PubMed Web of Science ®Google Scholar
• Thomas, J., & Harden, A. (2008). Methods for the thematic synthesis of qualitative research in systematic reviews. BMC Medical Research Methodology, 8(1), 1–10.
   PubMedGoogle Scholar
• Thow, A. M., Greenberg, S., Hara, M., Friel, S., duToit, A., & Sanders, D. (2018). Improving policy coherence for food security and nutrition in South Africa: A qualitative policy analysis. Food Security, 10(4), 1105–1130.
   Web of Science ®Google Scholar
• Thow, A. M., Verma, G., Soni, D., Soni, D., Beri, D. K., Kumar, P., Siegel, K. R., Shaikh, N., & Khandelwal, S. (2018). How can health, agriculture and economic policy actors work together to enhance the external food environment for fruit and vegetables? A qualitative policy analysis in India. Food Policy, 77, 143–151.
   Web of Science ®Google Scholar
• Trager, A. M. (2020). A better approach to fighting chronic diseases. Harvard Business Review. https://hbr.org/2020/09/a-better-approach-to-fighting-chronic-diseases
   Google Scholar
• Tripathy, J. P., & Prasad, B. M. (2018). Cost of diabetic care in India: An inequitable picture. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 12(3), 251–255.
   Web of Science ®Google Scholar
• Tusubira, A. K., Akiteng, A. R., Nakirya, B. D., Nalwoga, R., Ssinabulya, I., Nalwadda, C. K., & Schwartz, J. I. (2020). Accessing medicines for non-communicable diseases: Patients and health care workers’ experiences at public and private health facilities in Uganda. Plos One, 15(7), e0235696.
   Web of Science ®Google Scholar
• Tzeel, A. L. (2011). Diabetes benefit management: Evolving strategies for payers. The American Journal of Managed Care, 17(14), S384–S390.
   Google Scholar
• U.N. General Assembly. (2012). Political Declaration of the High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases. https://www.who.int/nmh/events/un_ncd_summit2011/political_declaration_en.pdf
   Google Scholar
• UNICEF. (2019). Programme guidance for early life prevention of non-communicable diseases. United Nations Children’s Fund (UNICEF).
   Google Scholar
• UNICEF. (2020). Nutrition, for every child: UNICEF Nutrition Strategy 2020-2030. https://www.unicef.org/reports/nutrition-strategy-2020-2030
   Google Scholar
• U.S. Department of State. (2011). Pink ribbon red ribbon overview. US Department of State. https://2009-2017.state.gov/r/pa/prs/ps/2011/09/172244.htm
   Google Scholar
• van de Vijver, S., Oti, S., Cohen Tervaert, T., Hankins, C., Kyobutungi, C., Gomez, G. B., Brewster, L., Agyemang, C., & Lange, J. (2013). Introducing a model of cardiovascular prevention in nairobi’s slums by integrating a public health and private-sector approach: The SCALE-UP study. Global Health Action, 6, 22510.
   Web of Science ®Google Scholar
• van Mourik, M. S. M., Cameron, A., Ewen, M., & Laing, R. O. (2010). Availability, price and affordability of cardiovascular medicines: A comparison across 36 countries using WHO/HAI data. BMC Cardiovascular Disorders, 10, 25.
   PubMed Web of Science ®Google Scholar
• Wearne, N., Okpechi, I. G., & Swanepoel, C. R. (2019). Nephrology in South Africa: Not yet ubuntu. Kidney Disease, 5(3), 189–196.
   Web of Science ®Google Scholar
• WHO. (2008). Health information systems. World Health Organization (WHO).
   Google Scholar
• WHO. (2013). Global action plan for the prevention and control of noncommunicable diseases 2013-2020. World Health Organization. http://apps.who.int/iris/bitstream/10665/94384/1/9789241506236_eng.pdf
   Web of Science ®Google Scholar
• WHO. (2016). SHAKE the salt habit: The SHAKE technical package for salt reduction. WHO. http://www.who.int/dietphysicalactivity/publications/shake-salt-habit/en/
   Google Scholar
• WHO. (2019). It’s time to walk the talk: WHO independent high-level commission on noncommunicable diseases final report.
   Google Scholar
• WHO. (2020). Countdown to 2023: WHO report on global trans-fat elimination 2020. World Health Organization (WHO).
   Google Scholar
• WHO. (2021, July 4-15). Strengthening NCD service delivery through UHC benefit package: Technical meeting report. https://www.who.int/publications/i/item/strengthening-ncd-service-delivery-through-uhc-benefit-package-technical-meeting-report-geneva-switzerland-14-15-july-2020
   Google Scholar
• WHO. (2021). WHO technical manual on tobacco tax policy and administration. World Health Organization (WHO).
   Google Scholar
• WHO. (2021). Noncommunicable diseases. https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases
   Google Scholar
• WHO GCM/NCD Working Group. (2018). Engaging with the private sector for the prevention and control of NCDs. World Health Organization (WHO).
   Google Scholar
• Williams, S. N. (2015). The incursion of ‘big food’ in middle-income countries: A qualitative documentary case study analysis of the soft drinks industry in China and India. Critical Public Health, 25(4), 455–473.
   Web of Science ®Google Scholar
• Wirtz, V. J., Turpin, K., Laing, R. O., Mukiira, C. K., & Rockers, P. C. (2018). Access to medicines for asthma, diabetes and hypertension in eight counties of Kenya. Tropical Medicine & International Health : TM & IH, 23(8), 879–885.
   Web of Science ®Google Scholar
• World Bank. (2013). The growing burden of non-communicable diseases in the Eastern Caribbean. https://documents.worldbank.org/en/publication/documents-reports/documentdetail/954761468224410323/the-growing-burden-of-non-communicable-diseases-in-the-eastern-caribbean
   Google Scholar
• World Economic Forum & PAHO. (2013). Multistakeholder collaboration for healthy - living toolkit for joint action. https://www.weforum.org/reports/multistakeholder-collaboration-healthy-living-toolkit-joint-action
   Google Scholar
• World Health Organization. (2021). Commercial determinants of health. World Health Organization. https://www.who.int/news-room/fact-sheets/detail/commercial-determinants-of-health
   Google Scholar
• You, H. W., Tajuddin, N. S. A., & Anwar, Y. A. M. S. (2019). Measuring availability, prices and affordability of ischaemic heart disease medicines in Bangi, Selangor, Malaysia. Malaysian Journal of Medical Science, 26(5), 113–121.
   Google Scholar